Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd., commonly referred to as Fuso Pharma, is a prominent player in the pharmaceutical industry, headquartered in Japan. Established in 1950, the company has made significant strides in developing innovative healthcare solutions, primarily focusing on prescription pharmaceuticals and over-the-counter products. With a strong operational presence in Asia and beyond, Fuso Pharma is renowned for its commitment to quality and research-driven approaches. The company’s core offerings include a diverse range of therapeutic agents, particularly in the fields of oncology and infectious diseases, distinguished by their efficacy and safety profiles. Fuso Pharmaceutical Industries has achieved notable recognition within the market, positioning itself as a trusted name in healthcare. Its dedication to advancing medical science and improving patient outcomes underscores its pivotal role in the global pharmaceutical landscape.
DitchCarbon Score
How does Fuso Pharmaceutical Industries,Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fuso Pharmaceutical Industries,Ltd.'s score of 14 is higher than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Fuso Pharmaceutical Industries,Ltd.'s reported carbon emissions
Fuso Pharmaceutical Industries, Ltd., headquartered in Japan, currently does not have available data on carbon emissions or specific climate commitments. As such, there are no reported figures for emissions in kg CO2e, nor are there defined reduction targets or initiatives outlined in their sustainability strategy. The absence of this information suggests that the company may still be in the early stages of developing a comprehensive climate action plan or reporting framework. In the pharmaceutical industry, companies are increasingly recognising the importance of addressing climate change, and it is anticipated that Fuso Pharmaceutical Industries will align with industry standards in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fuso Pharmaceutical Industries,Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
